Teladoc Health Q4 EPS disappoints; weak Q1 2025 guidance

 

• Teladoc Health (NYSE:TDOC) is down ~11% in after-hours trading Wednesday after reporting Q4 2024 results that missed on the bottom line.
• Net loss per share, basic and diluted, of -$0.28 compares to -$0.17 in the year-ago period.
• The telehealth provider's share price is also under pressure as Q1 2025 financial guidance came in weak. Teladoc is projecting EPS of ($0.40)-($0.15). Consensus is -$0.37. For revenue, the company is anticipating $608M-$629M. Consensus is $633.03M.
• Teladoc also issued 2025 full-year guidance. Both the EPS and revenue ranges included the consensus figures.
• In Q4, although the number of U.S. integrated care members rose 5% year-over-year, average monthly revenue per member declined 2%.  

https://www.msn.com/en-us/money/markets/teladoc-health-drops-11-as-q4-eps-disappoints-weak-q1-2025-guidance/ar-AA1zRz4V?ocid=finance-verthp-feeds